Predictive Efficacy of Fecal Calprotectin Assay by Magnetic Particle Chemiluminescence for Mucosal Healing in Moderate-to-Severe Ulcerative Colitis Patients Undergoing Initial Biologic Therapy（PRECAL） | MicrobiomeTrials
Predictive Efficacy of Fecal Calprotectin Assay by Magnetic Particle Chemiluminescence for Mucosal Healing in Moderate-to-Severe Ulcerative Colitis Patients Undergoing Initial Biologic Therapy（PRECAL）
ENROLLING_BY_INVITATIONOBSERVATIONAL
Trial Details
Start: 2026-06-18Est. Completion: 2027-06-30
Enrollment target: 200 participants
Locations
Peking University People's Hospital, Beijing, Beijing Municipality, China
Chongqing General Hospital, Chongqing, Chongqing Municipality, China
Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China
Shengjing Hospital of China Medical University,, Shengyang, Liaoning, China
Qilu Hospital (Qingdao), Shandong University, Qingdao, Shandong, China
Tangdu Hospital, Air Force Medical University, Xi’an, Shanxi, China
The First Affiliated Hospital of Xi'an Medical University, Xi’an, Shanxi, China
The Second Hospital of Dalian Medical University, Dalian, China
Other microbiome trials you might be interested in